In previous studies, the ApoE protein has been proposed as a biomarker for prion diseases [48], [49], [50], [51] in addition to its role in the Alzheimer's disease pathway [52], [53]. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.